CSPC Pharmaceutical Group Limited (1093.HK)
HKD 4.79
(0.84%)
HKD 4.79
(0.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 34.59 Billion | 35.97 Billion | 33.58 Billion | 28.02 Billion | 25.06 Billion | 18.46 Billion |
| Cost of Revenue | 10.2 Billion | 10.09 Billion | 8.11 Billion | 7.03 Billion | 7.02 Billion | 6.24 Billion |
| Gross Profit | 24.39 Billion | 25.88 Billion | 25.47 Billion | 20.99 Billion | 18.04 Billion | 12.21 Billion |
| Operating Expenses | 16.71 Billion | 17.98 Billion | 17.94 Billion | 14.89 Billion | 12.99 Billion | 8.23 Billion |
| Selling, General and Administrative Expenses | 11.36 Billion | 13.35 Billion | 13.8 Billion | 11.64 Billion | 10.72 Billion | 7.12 Billion |
| Research and Development Expenses | 5.35 Billion | 4.63 Billion | 4.13 Billion | 3.24 Billion | 2.26 Billion | 1.39 Billion |
| Other Expenses | - | 814.84 Million | 545.69 Million | - | - | 181.19 Million |
| Cost and Expenses | 26.91 Billion | 28.08 Billion | 26.05 Billion | 21.92 Billion | 20.01 Billion | 14.48 Billion |
| Operating Income | 7.68 Billion | 7.89 Billion | 7.52 Billion | 6.1 Billion | 5.04 Billion | 4.05 Billion |
| Interest Expense | 25.89 Million | 28.94 Million | 9.23 Million | 13.74 Million | 36.76 Million | 76.9 Million |
| Income Tax Expense | 1.45 Billion | 1.57 Billion | 1.39 Billion | 1.3 Billion | 1.01 Billion | 766.7 Million |
| Earnings before Tax | 8.22 Billion | 8.83 Billion | 8.22 Billion | 7.16 Billion | 5.17 Billion | 3.95 Billion |
| Net Income | 5.87 Billion | 6.09 Billion | 5.6 Billion | 5.15 Billion | 4.21 Billion | 3.21 Billion |
| Earnings Per Share Basic | 0.55 | 0.59 | 0.57 | 0.49 | 0.35 | 0.27 |
| Earnings Per Share Diluted | 0.55 | 0.59 | 0.57 | 0.49 | 0.35 | 0.27 |
| Weighted Average Shares Outstanding | 11.87 Billion | 11.91 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.98 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.87 Billion | 11.91 Billion | 11.95 Billion | 11.95 Billion | 11.95 Billion | 11.98 Billion |
| Gross Margin | 0.71 | 0.72 | 0.76 | 0.75 | 0.72 | 0.66 |
| EBIT Margin | 0.25 | 0.25 | 0.26 | 0.25 | 0.23 | 0.25 |
| Profit Margin | 0.17 | 0.17 | 0.17 | 0.18 | 0.17 | 0.17 |
| EBITDA | 8.53 Billion | 8.65 Billion | 9.27 Billion | 8.08 Billion | 5.35 Billion | 5.31 Billion |
| Earnings Before Tax Margin | 0.22 | 0.22 | 0.22 | 0.22 | 0.20 | 0.22 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 17.49 Billion | 16.6 Billion | 34.75 Billion | 7.78 Billion | 8.02 Billion | 8.05 Billion |
| Cost of Revenue | 4.97 Billion | 4.78 Billion | 10.24 Billion | 2.23 Billion | 2.3 Billion | 2.53 Billion |
| Gross Profit | 12.52 Billion | 11.81 Billion | 24.5 Billion | 5.55 Billion | 5.71 Billion | 5.51 Billion |
| Operating Expenses | 8.54 Billion | 8.02 Billion | 16.76 Billion | 3.76 Billion | 4.02 Billion | 3.77 Billion |
| Selling, General and Administrative Expenses | 5.81 Billion | 5.29 Billion | - | 2.44 Billion | 2.68 Billion | 2.75 Billion |
| Research and Development Expenses | 2.73 Billion | 2.72 Billion | - | 1.37 Billion | 1.29 Billion | 1 Billion |
| Other Expenses | - | 1.78 Million | 3.65 Million | 136.93 Million | 210.43 Million | 16.64 Million |
| Cost and Expenses | 13.51 Billion | 12.81 Billion | 27.01 Billion | 6 Billion | 6.32 Billion | 6.3 Billion |
| Operating Income | 3.97 Billion | 3.79 Billion | 7.73 Billion | 1.93 Billion | 1.9 Billion | 1.74 Billion |
| Interest Expense | - | 9.01 Million | 25.89 Million | 6.15 Million | 6.29 Million | 4.42 Million |
| Income Tax Expense | 805.53 Million | 748.85 Million | 1.45 Billion | 341.22 Million | 311.65 Million | 311.86 Million |
| Earnings before Tax | 4.08 Billion | 4.04 Billion | 8.22 Billion | 1.92 Billion | 1.9 Billion | 1.78 Billion |
| Net Income | 3.24 Billion | 3.13 Billion | 5.87 Billion | 1.52 Billion | 1.53 Billion | 1.42 Billion |
| Earnings Per Share Basic | 0.27 | 0.26 | - | - | 0.28 | 0.12 |
| Earnings Per Share Diluted | 0.27 | 0.26 | - | - | 0.28 | 0.12 |
| Weighted Average Shares Outstanding | 11.84 Billion | 11.85 Billion | 11.87 Billion | - | 11.89 Billion | 11.91 Billion |
| Weighted Average Shares Outstanding (Diluted) | 11.83 Billion | 11.85 Billion | 11.87 Billion | - | 11.89 Billion | 11.91 Billion |
| Gross Margin | 0.72 | 0.71 | 0.71 | 0.71 | 0.71 | 0.69 |
| EBIT Margin | 0.26 | 0.27 | - | 0.25 | 0.24 | 0.22 |
| Profit Margin | 0.19 | 0.19 | 0.17 | 0.20 | 0.19 | 0.18 |
| EBITDA | 4.56 Billion | 4.42 Billion | - | 1.93 Billion | 1.9 Billion | 1.78 Billion |
| Earnings Before Tax Margin | 0.23 | 0.23 | 0.22 | 0.25 | 0.24 | 0.22 |
3544
SVNDF
0640
009440
SDMU
KOPI